GLP-1 secretion by microglial cells and decreased CNS expression in obesity

Repertoire of microglial and macrophage responses after spinal cord injury

David, S., & Kroner, A. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3053 · Cited by 1,437 · see citing works

Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice

Coleman, D. L. (1978) · Diabetologia · doi:10.1007/bf00429772 · Cited by 1,307 · see citing works

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · see citing works

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation.

Henn, A. (2009) · ALTEX · doi:10.14573/altex.2009.2.83 · Cited by 660 · see citing works

The role of gut hormones in glucose homeostasis

Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 611 · see citing works

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.

(2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-27 · Cited by 393 · see citing works

Peptide hormone exendin‐4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease

Bertilsson, G., Patrone, C., Zachrisson, O., Andersson, A., Dannaeus, K., Heidrich, J., Kortesmaa, J., Mercer, A., Nielsen, E., Rönnholm, H., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21483 · Cited by 345 · see citing works

GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

Li, Y., Duffy, K. B., Ottinger, M. A., Ray, B., Bailey, J. A., Holloway, H. W., Tweedie, D., Perry, T., Mattson, M. P., Kapogiannis, D., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1314 · Cited by 319 · see citing works

Endothelial inflammation in insulin resistance

SJOHOLM, A., & NYSTROM, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70804-7 · Cited by 278 · see citing works

Endothelial inflammation in insulin resistance

Sjöholm, Å., & Nyström, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17912-4 · Cited by 278 · see citing works

The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?

Kroner, Z. (2009) · PubMed · Cited by 246 · see citing works

Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes

Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S., & Oka, J.-I. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.008 · Cited by 207 · see citing works

Increased Brain Fatty Acid Uptake in Metabolic Syndrome

Karmi, A., Iozzo, P., Viljanen, A. P. M., Hirvonen, J., Fielding, B. A., Virtanen, K. A., Oikonen, V., Kemppainen, J., Viljanen, T., Guiducci, L., et al. (2010) · Diabetes · doi:10.2337/db09-0138 · Cited by 204 · see citing works

Partition of Unesterified Fatty Acids in Normal and Nephrotic Syndrome Serum and Its Effect on Serum Electrophoretic Pattern1

Shafrir, E. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103770 · Cited by 184 · see citing works

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

Perry, T., Holloway, H. W., Weerasuriya, A., Mouton, P. R., Duffy, K. B., Mattison, J. A., & Greig, N. H. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.028 · Cited by 183 · see citing works

Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line1

BRUBAKER, P. L., Schloos, J., & Drucker, D. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6228 · Cited by 168 · see citing works

Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei

Vrang, N., Hansen, M. B., Larsen, P. J., & Tang‐Christensen, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.043 · Cited by 154 · see citing works

Lipopolysaccharide increases microglial GLT‐1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF‐α

Persson, M., Brantefjord, M., Hansson, E., & Rönnbäck, L. (2005) · Glia · doi:10.1002/glia.20191 · Cited by 154 · see citing works

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test

Isacson, R., Nielsen, E. I., Dannaeus, K., Bertilsson, G., Patrone, C., Zachrisson, O., & Wikström, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.008 · Cited by 150 · see citing works

Enhancing the GLP‐1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells

Li, Y., Tweedie, D., Mattson, M. P., Holloway, H. W., & Greig, N. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06731.x · Cited by 149 · see citing works

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

Laakso, M., Zilinskaite, J., Hansen, T. F., Boesgaard, T. W., Vänttinen, M., Stančáková, A., Jansson, P., Pellmé, F., Holst, J. J., Kuulasmaa, T., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0899-2 · Cited by 145 · see citing works

Impairment of Dendritic Cell Functionality and Steady-State Number in Obese Mice

Macia, L., Delacre, M., Abboud, G., Ouk, T., Delanoye, A., Verwaerde, C., Saule, P., & Wolowczuk, I. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5997 · Cited by 140 · see citing works

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats

Darsalia, V., Mansouri, S., Ortsäter, H., Olverling, A., Nozadze, N., Krizhanovskii, C., Iverfeldt, K., Tracy, L. M., Grankvist, N., Sjöholm, Å., et al. (2011) · Clinical Science · doi:10.1042/cs20110374 · Cited by 129 · see citing works

Characterization of plasma lipids in genetically obese mice: The mutants obese, diabetes, fat, tubby, and lethal yellow

Nishina, P. M., Lowe, S., Wang, J., & Paigen, B. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90194-5 · Cited by 122 · see citing works

Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients

Giorda, C. B., Avogaro, A., Maggini, M., Lombardo, F. L., Mannucci, E., Turco, S., Alegiani, S. S., Raschetti, R., Velussi, M., Ferrannini, E., et al. (2007) · Stroke · doi:10.1161/01.str.0000260100.71665.2f · Cited by 117 · see citing works

Increases in serum unbound free fatty acid levels following coronary angioplasty

Kleinfeld, A. M., Prothro, D., Brown, D., Davis, R. C., Richieri, G. V., & DeMaria, A. N. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00651-0 · Cited by 111 · see citing works

Minireview: Finding the Sweet Spot: Peripheral Versus Central Glucagon-Like Peptide 1 Action in Feeding and Glucose Homeostasis

Williams, D. L. (2009) · Endocrinology · doi:10.1210/en.2009-0220 · Cited by 98 · see citing works

Palmitate and insulin synergistically induce IL-6 expression in human monocytes

Bunn, R. C., Cockrell, G. E., Ou, Y., Thrailkill, K. M., Lumpkin, C. K., & Fowlkes, J. L. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-73 · Cited by 82 · see citing works

Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans

Krogh‐Madsen, R., Plomgaard, P., Akerstrom, T. C. A., Møller, K., Schmitz, O., & Pedersen, B. K. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00507.2007 · Cited by 78 · see citing works

Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells

Samokhvalov, V., Bilan, P. J., Schertzer, J. D., Antonescu, C. N., & Klip, A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90667.2008 · Cited by 69 · see citing works

The Saturated Fatty Acid Palmitate Induces Human Monocytic Cell Toxicity Toward Neuronal Cells: Exploring a Possible Link Between Obesity-Related Metabolic Impairments and Neuroinflammation

Little, J. P., Madeira, J. M., & Klegeris, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111262 · Cited by 44 · see citing works

The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide

Ramberg, V., Tracy, L. M., Samuelsson, M., Nilsson, L. N. G., & Iverfeldt, K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-34 · Cited by 33 · see citing works

Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line

Brubaker, P. L. (1998) · Endocrinology · doi:10.1210/en.139.10.4108 · Cited by 26 · see citing works

Untitled work

Merchenthaler (1999) · doi:10.1002/(sici)1096-9861(19990111)403:2

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 503 · see citing works

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · see citing works

Insulin resistance and Parkinson’s disease: A new target for disease modification?

Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

GLP-1 and weight loss: unraveling the diverse neural circuitry

Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2015 · Cited by 290 · see citing works

The role of type 2 diabetes in neurodegeneration

Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 276 · see citing works

Neuroinflammation in animal models of traumatic brain injury

Chiu, C., Liao, Y.-E., Yang, L.-Y., Wang, J.-Y., Tweedie, D., Karnati, H. K., Greig, N. H., & Wang, J. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.06.018 · Cited by 248 · see citing works

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248 · see citing works

Brain insulin resistance: role in neurodegenerative disease and potential for targeting

Hölscher, C. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1738383 · Cited by 180 · see citing works

Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes

Muscogiuri, G., DeFronzo, R. A., Gastaldelli, A., & Holst, J. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.001 · Cited by 171 · see citing works

GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality

Anderberg, R. H., Richard, J. E., Hansson, C., Nissbrandt, H., Bergquist, F., & Skibicka, K. P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.021 · Cited by 170 · see citing works

Cell Culture Models of Fatty Acid Overload: Problems and Solutions

Alsabeeh, N., Chausse, B., Kakimoto, P. A., Kowaltowski, A. J., & Shirihai, O. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.11.006 · Cited by 167 · see citing works

Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders

Hölscher, C. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15508 · Cited by 147 · see citing works

Diet in Parkinson’s Disease: Critical Role for the Microbiome

Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145 · see citing works

The nature, significance, and glucagon‐like peptide‐1 analog treatment of brain insulin resistance in Alzheimer's disease

Talbot, K., & Wang, H.-Y. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.007 · Cited by 140 · see citing works

A New Treatment Strategy for Parkinson's Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway

Kim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136 · see citing works

Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity

Jena, P. K., Sheng, L., Di Lucente, J., Jin, L., Maezawa, I., & Wan, Y. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201700984rr · Cited by 134 · see citing works

GLP-1’s role in neuroprotection: a systematic review

Erbil, D., Eren, C. Y., Demirel, Ç., Küçüker, M. U., Solaroğlu, İ., & Eser, H. Y. (2019) · Brain Injury · doi:10.1080/02699052.2019.1587000 · Cited by 128 · see citing works

Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol

Eren, C. Y., Yigit, A., Dogruoz, E., & Eser, H. Y. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.614884 · Cited by 129 · see citing works

The benefits of GLP1 receptors in cardiovascular diseases

Ferhatbegović, L., Mršić, D., & Macić-Džanković, A. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1293926 · Cited by 127 · see citing works

Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses

Lee, C., Jeon, S. J., Cho, K. S., Moon, E., Sapkota, A., Jun, H., Ryu, J. H., & Choi, J. W. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0550-2 · Cited by 126 · see citing works

Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease

Badawi, G. A., Fattah, M. A. A. E., Zaki, H. F., & Sayed, M. I. E. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0331-6 · Cited by 123 · see citing works

Alleviation of depression by glucagon-like peptide 1 through the regulation of Neuroinflammation, neurotransmitters, neurogenesis, and synaptic function

Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109 · see citing works

Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies

Vargas-Soria, M., Garcı́a-Alloza, M., & Corraliza-Gómez, M. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02740-x · Cited by 109 · see citing works

Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors

Spielman, L. J., Gibson, D. L., & Klegeris, A. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.03.004 · Cited by 100 · see citing works

Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease

Athauda, D. S., & Foltynie, T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.023 · Cited by 97 · see citing works

Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events

Wiciński, M., Socha, M. W., Malinowski, B., Wódkiewicz, E., Walczak, M., Górski, K. M., Słupski, M., & Pawlak-Osińska, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051050 · Cited by 92 · see citing works

The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases

Cheng, D., Yang, S., Zhao, X., & Wang, G. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s348055 · Cited by 84 · see citing works

Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta

Hidalgo‐Lanussa, O., Ávila-Rodriguez, M., Báez-Jurado, E., Zamudio-Rodriguez, J. A., Echeverrı́a, V., García‐Segura, L. M., & Barreto, G. E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0777-y · Cited by 67 · see citing works

Microglia and BDNF at the crossroads of stressor related disorders: Towards a unique trophic phenotype

Prowse, N. A., & Hayley, S. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.018 · Cited by 67 · see citing works

Exposure to the Saturated Free Fatty Acid Palmitate Alters BV-2 Microglia Inflammatory Response

Tracy, L. M., Bergqvist, F., Ivanova, E. V., Jacobsen, K. T., & Iverfeldt, K. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0068-7 · Cited by 63 · see citing works

Palmitic Acid and Oleic Acid Differently Modulate TLR2-Mediated Inflammatory Responses in Microglia and Macrophages

Howe, A.-M., Burke, S., O’Reilly, M. E., McGillicuddy, F. C., & Costello, D. A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02756-z · Cited by 61 · see citing works

Distinct metabolic patterns during microglial remodeling by oleate and palmitate

Chausse, B., Kakimoto, P. A., Caldeira-da-Silva, C. C., Chaves-Filho, A. B., Yoshinaga, M. Y., da Silva, R. P., Miyamoto, S., & Kowaltowski, A. J. (2019) · Bioscience Reports · doi:10.1042/bsr20190072 · Cited by 59 · see citing works

Neuroprotective effects of vildagliptin on drug induced Alzheimer's disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways

Rasha, R. Y., El-Yamany, M. F., Saad, M. A., & El-Sahar, A. E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173612 · Cited by 59 · see citing works

Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease

de Nazareth, A. M. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-020002 · Cited by 60 · see citing works

GLP-1 programs the neurovascular landscape

Chen, B., Yu, X., HORVATH-DIANO, C., Ortuño, M. J., Tschöp, M. H., Jastreboff, A. M., & Schneeberger, M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.003 · Cited by 58 · see citing works

Diet-induced cellular neuroinflammation in the hypothalamus: Mechanistic insights from investigation of neurons and microglia

Tran, D. Q., Tse, E. K., Kim, M. H., & Belsham, D. D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.05.015 · Cited by 54 · see citing works

Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats

Badawi, G. A., Fattah, M. A. A. E., Zaki, H. F., & Sayed, M. I. E. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-9998-3 · Cited by 53 · see citing works

Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease

Yang, X., Feng, P., Ji, R., Ren, Y., Wei, W., & Hölscher, C. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2079492 · Cited by 51 · see citing works

Direct and indirect effects of lipids on microglia function

Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50 · see citing works

The regulation of function, growth and survival of GLP-1-producing L-cells

Kuhre, R. E., Holst, J. J., & Krizhanovskii, C. (2015) · Clinical Science · doi:10.1042/cs20150154 · Cited by 48 · see citing works

Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury

Bader, M., Li, Y., Tweedie, D., Shlobin, N. A., Bernstein, A., Rubovitch, V., Tovar‐y‐Romo, L. B., DiMarchi, R. D., Hoffer, B. J., Greig, N. H., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00356 · Cited by 48 · see citing works

DA5‐CH and Semaglutide Protect against Neurodegeneration and Reduce α‐Synuclein Levels in the 6‐OHDA Parkinson’s Disease Rat Model

Zhang, L., Li, C., Zhang, Z., Zhang, Z., Jin, Q., Li, L., & Hölscher, C. (2022) · Parkinson s Disease · doi:10.1155/2022/1428817 · Cited by 43 · see citing works

A Comprehensive Review on Weight Gain following Discontinuation of Glucagon‐Like Peptide‐1 Receptor Agonists for Obesity

Ahmed, I. A. B. (2024) · Journal of Obesity · doi:10.1155/2024/8056440 · Cited by 43 · see citing works

The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders

Raval, U., Harary, J. M., Zeng, E., & Pasinetti, G. M. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1775585 · Cited by 44 · see citing works

Palmitate Induces an Anti-Inflammatory Response in Immortalized Microglial BV-2 and IMG Cell Lines that Decreases TNFα Levels in mHypoE-46 Hypothalamic Neurons in Co-Culture

Kim, S. M., McIlwraith, E. K., Chalmers, J. A., & Belsham, D. D. (2018) · Neuroendocrinology · doi:10.1159/000494759 · Cited by 37 · see citing works

Novel Trajectories of Bromocriptine Antidiabetic Action: Leptin-IL-6/ JAK2/p-STAT3/SOCS3, p-IR/p-AKT/GLUT4, PPAR-γ/Adiponectin, Nrf2/PARP-1, and GLP-1

Reda, E., Hassaneen, S. K., & El-Abhar, H. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00771 · Cited by 36 · see citing works

Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects

Krizhanovskii, C., Fransson, L., Wolbert, P., & Ortsäter, H. (2015) · Clinical Science · doi:10.1042/cs20140719 · Cited by 35 · see citing works

Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury

Bader, M., Li, Y., Lecca, D., Rubovitch, V., Tweedie, D., Glotfelty, E. J., Rachmany, L., Kim, H. K., Choi, H., Hoffer, B. J., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.023 · Cited by 34 · see citing works

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways

Green, H., Tsitsi, P., Markaki, I., Aarsland, D., & Svenningsson, P. (2019) · CNS Drugs · doi:10.1007/s40263-018-0601-x · Cited by 31 · see citing works

Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases

Li, Y., Li, L., & Hölscher, C. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0018 · Cited by 28 · see citing works

Diabetes, insulin and new therapeutic strategies for Parkinson’s disease: Focus on glucagon-like peptide-1 receptor agonists

Labandeira, C. M., Bau, A. F., Ron, D. A., Muñoz, A., Losada, G. A., Koukoulis, A., Romero-López, J., & Rodriguez-Perez, A. I. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100914 · Cited by 28 · see citing works

The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders

Mansur, R. B., Fries, G. R., Trevizol, A. P., Subramaniapillai, M., Lovshin, J. A., Lin, K., Vinberg, M., Ho, R., Brietzke, E. M., & McIntyre, R. S. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.10.007 · Cited by 26 · see citing works

Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation

Zhang, H., Chu, Y., Zheng, H., Wang, J., Song, B., & Sun, Y. (2020) · Aging · doi:10.18632/aging.202162 · Cited by 25 · see citing works

Old wines in new bottles: Repurposing opportunities for Parkinson's disease

Kakkar, A. K., Singh, H., & Medhi, B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.023 · Cited by 25 · see citing works

Cardiorenal Metabolic Syndrome and Diabetic Cognopathy

Hayden, M. R., Banks, W. A., Shah, G. N., Gu, Z., & Sowers, J. R. (2013) · Cardiorenal Medicine · doi:10.1159/000357113 · Cited by 24 · see citing works

Retatrutide—A Game Changer in Obesity Pharmacotherapy

Katsi, V., Koutsopoulos, G., Fragoulis, C., Dimitriadis, K., & Tsioufis, K. (2025) · Biomolecules · doi:10.3390/biom15060796 · Cited by 29 · see citing works

Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development

Deselms, H., Maggio, N., Rubovitch, V., Chapman, J., Schreiber, S., Tweedie, D., Kim, D. S., Greig, N. H., & Pick, C. G. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.02.002 · Cited by 23 · see citing works

Gut–Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond

Zißler, J., Rothhammer, V., & Linnerbauer, M. (2024) · Cells · doi:10.3390/cells13060497 · Cited by 24 · see citing works

Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune/autoinflammatory diseases

Deng, S., Chen, Z., & Shi, Y. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01486-8 · Cited by 25 · see citing works

Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis

Eser, H. Y., Appadurai, V., Eren, C. Y., Yazıcı, D., Chen, C., Öngür, D., Pizzagalli, D. A., Werge, T. M., & Hall, M. (2020) · Acta Neuropsychiatrica · doi:10.1017/neu.2020.14 · Cited by 23 · see citing works

Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer’s Disease and Parkinson’s Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies

Hölscher, C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01226-z · Cited by 23 · see citing works

Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients

Wu, P., Zhao, Y., Zhuang, X., Sun, A., Zhang, Y., & Ni, Y. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.08.012 · Cited by 20 · see citing works

Incretin-based therapeutics for the treatment of neurodegenerative diseases

Vear, A., Heneka, M. T., & Clemmensen, C. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01263-4 · Cited by 21 · see citing works

DPP4 Deficiency Preserved Cardiac Function in Abdominal Aortic Banding Rats

Ku, H.-C., & Su, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085634 · Cited by 19 · see citing works

Tip60/KAT5 Histone Acetyltransferase Is Required for Maintenance and Neurogenesis of Embryonic Neural Stem Cells

Tominaga, K., Sakashita, E., Kasashima, K., Kuroiwa, K., Nagao, Y., Iwamori, N., & Endo, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032113 · Cited by 18 · see citing works

Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease

Verma, A., & Goyal, A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176936 · Cited by 17 · see citing works

Brain Innate Immune Response in Diet-Induced Obesity as a Paradigm for Metabolic Influence on Inflammatory Signaling

Macedo, F. P., dos Santos, L. S., Glezer, I., & da Cunha, F. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00342 · Cited by 16 · see citing works

A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease

Zhang, Z., Shi, M., Li, Z., Ling, Y., Zhai, L., Yuan, Y., Ma, H., Li, H., Li, Z., Zhang, Z., et al. (2023) · Parkinson s Disease · doi:10.1155/2023/7427136 · Cited by 15 · see citing works

The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction

Chunchai, T., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0151-9 · Cited by 14 · see citing works

Glucagon-like peptide-1 attenuated carboxymethyl lysine induced neuronal apoptosis via peroxisome proliferation activated receptor-γ

Zhang, H., Song, B., Zhu, W., Liu, L., He, X., Wang, Z., An, K., Cao, W., Shi, J., & Wang, S. (2021) · Aging · doi:10.18632/aging.203351 · Cited by 14 · see citing works

Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids

Mi, N., Ma, L., Li, X., Fu, J., Bu, X., Liu, F., Yang, F., Zhang, Y., & Yao, L. (2023) · Open Medicine · doi:10.1515/med-2023-0849 · Cited by 13 · see citing works

Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy

Zhou, Y., Li, Z., Cao, X., Ma, H., White, P. F., Xu, X., Jiang, Y., Sun, X.-J., & Cui, Y. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.007 · Cited by 13 · see citing works

Recent Advances in Drug Repurposing for Parkinson’s Disease

Chen, X., Gumina, G., & Virga, K. G. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180719144850 · Cited by 13 · see citing works

Just a Gut Feeling: Central Nervous Effects of Peripheral Gastrointestinal Hormones

Roth, C. L., & Doyle, R. P. (2017) · Endocrine development · doi:10.1159/000475734 · Cited by 11 · see citing works

Repurposing GLP1 agonists for neurodegenerative diseases

Markaki, I., Winther, K., Catrina, S., & Svenningsson, P. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.007 · Cited by 11 · see citing works

Age-Related Decrease in Glucagon-Like Peptide-1 in Mouse Prefrontal Cortex but Not in Hippocampus Despite the Preservation of Its Receptor

Ohshima, R. (2015) · American Journal of BioScience · doi:10.11648/j.ajbio.20150301.13 · Cited by 10 · see citing works

Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review

Sjöholm, Å., Bennet, L., & Nilsson, P. M. (2025) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2025.2455136 · Cited by 10 · see citing works

Central Functions of Glucagon-like Peptide-1: Roles in Energy Regulation and Neuroprotection

McGrath, R. T. (2015) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000.152 · Cited by 9 · see citing works

L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease

Elabi, O. F., Davies, J. S., & Lane, E. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212346 · Cited by 9 · see citing works

Bariatric Surgery and Gut-Brain-Axis Driven Alterations in Cognition and Inflammation

Custers, E., Franco, A., & Kiliaan, A. J. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s437156 · Cited by 8 · see citing works

Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting α-synuclein and neuroprotection in the treatment of Parkinson's disease

Siddique, A. H. H., & Kale, P. P. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.08.011 · Cited by 9 · see citing works

A Research Update on Exendin-4 as a Novel Molecule Against Parkinson’s Disease

Singh, N. K., Singh, A., Varshney, M., & Agrawal, R. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230529093314 · Cited by 8 · see citing works

Crosstalk of kidney and brain in diabetes-related cognitive impairment and therapeutic strategies

Xu, C., Miao, H., Chen, Y., & Liao, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1562518 · Cited by 7 · see citing works

Lipidomics Analysis of Human HMC3 Microglial Cells in an In Vitro Model of Metabolic Syndrome

Chmielarz, M., Bromke, M. A., Olbromski, M., Środa-Pomianek, K., Frej−Mądrzak, M., Dzięgiel, P., & Sobieszczańska, B. (2024) · Biomolecules · doi:10.3390/biom14101238 · Cited by 6 · see citing works

The Interaction of Food Allergy and Diabetes: Food Allergy Effects on Diabetic Mice by Intestinal Barrier Destruction and Glucagon-like Peptide 1 Reduction in Jejunum

Gu, Y., Yao, L., Jiang, T., & Che, H. (2022) · Foods · doi:10.3390/foods11233758 · Cited by 5 · see citing works

Central GLP-1 Resistance Induced by Severe Traumatic Brain Injury Was Associated with Persistent Hyperglycemia in Humans

Zhou, M., Du, M., Tang, R., Liu, H., Gao, Z., Wang, Y., You, H., Hao, J.-W., Ji, Z., Wang, D., et al. (2023) · Neuroendocrinology · doi:10.1159/000529438 · Cited by 4 · see citing works

Plasma glucagon-like peptide 1 was associated with hospital-acquired infections and long-term mortality in burn patients

Yin, H., Hao, J.-W., Chen, Q., Li, F., Yin, S., Zhou, M., Zhang, Q., Yao, Y.-M., & Chai, J. (2020) · Surgery · doi:10.1016/j.surg.2020.01.004 · Cited by 4 · see citing works

Lateral Septum as a Key Integrative Regulator of Feeding: Role of the GLP ‐1/ GLP ‐ 1R System

Dib, T., Covarrubias, M. J., Escobar, A. P., Renard, G. M., Bravo, J. A., & Sotomayor‐Zárate, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70301 · Cited by 3 · see citing works

Glucagon-like peptide-1 receptor agonists: prospects for use in the treatment of age-related diseases and aging

Bobok, N., & Halushko, O. A. (2025) · Problems of ageing and longevity (Ukraine) · doi:10.71012/pro-ageing-2025-4-05 · Cited by 1 · see citing works

Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists

Helal, M. M., Almosilhy, N. A., Abo‐elnour, D. E., Jaffal, R., Allam, E. G., Almosilhy, M. A., Batarseh, S. F., & Meshref, M. M. (2026) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2026.2627901 · Cited by 2 · see citing works

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

Zhang, L., Peng, F., Wanting, Z., Qianqian, J., Zhang, Z., Bai, B., Xue, G., & Hölscher, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1825379 · Cited by 1 · see citing works

The dual role of the immune system in the pathogenesis of traumatic brain injury

Лисяный, Н. И. (2019) · Ukrainian Neurosurgical Journal · doi:10.25305/unj.155107 · Cited by 1 · see citing works

Development of therapeutics for the treatment of diabetic brain complications

Mansouri, S. (2013) · Figshare

Central Functions of Glucagon-like Peptide-1: Roles in Energy Regulation and

McGrath, N., Glastras, S. J., HOCKING, S. L., Tjoeng, I., Krause, M., Fulcher, G. R., & McGrath, R. T. (2015)

The Effect of High-Intensity Interval Training on GLP-1, Appetite, and Weight in Obese Rats

Sepehri, H., Nemati, J., Jahromi, M. K., Eskandari, M. H., & Daryanoosh, F. (2021) · مجله علمی پزشکی جندی شاپور · doi:10.32598/jsmj.20.3.1975

DISORDERS OF THE GLIAL SYSTEM OF CELLULAR FORMATIONS (GLIOM) OF THE BRAIN IN CONDITIONS OF NEUROTRAUMA

(2020) · Наукові перспективи (Naukovì perspektivi) · doi:10.32689/2708-7530-2020-3(3)-162-172

Agonisti del recettore del GLP1 e infiammazione: non solo compenso glicemico

Costanzo, G., & Frasca, F. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01064-x

Efecto protector de la tibolona en un modelo inflamatorio de microglía estimulado por palmitato

Hidalgo‐Lanussa, O. (2020) · doi:10.11144/javeriana.10554.38564

Physical exercise promotes memory function in diabetes mellitus rats: a look at glucagon like peptide-1 and glucagon like peptide-1 receptor

Andraini, T., Mardatillah, J., Kartinah, N. T., Paramita, N., Santoso, ‪. I. S., Yolanda, S., Puspasari, B. C., & Rusli, H. (2022) · Comparative Exercise Physiology · doi:10.3920/cep220020

Glucagon-like peptide-2 reduces the obesity-associated inflammation in the brain

Nuzzo, D., Baldassano, S., Amato, A., Picone, P., Galizzi, G., Caldara, G., Carlo, M. D., & Mulè, F. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.012 · Cited by 43 · see citing works

A High-Fat Diet Increases Activation of the Glucagon-Like Peptide-1-Producing Neurons in the Nucleus Tractus Solitarii: an Effect that is Partially Reversed by Drugs Normalizing Glycemia

Lietzau, G., Ntika, S., Pintana, H., Tracy, L. M., Klein, T., Nyström, T., Darsalia, V., Patrone, C., & Krizhanovskii, C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01079-2 · Cited by 3 · see citing works

Dysfunction of a Peripheral Lipid Sensor Gpr120 Causes Pgd2-microglia-provoked NeuroinflammationPreprint

Iwasa, K., Yamamoto, S., Yamashina, K., Sakemoto, C., Yagishita-Kyo, N., Maruyama, K., Awaji, T., Takei, Y., Hirasawa, A., & Yoshikawa, K. (2020) · Research Square · doi:10.21203/rs.3.rs-114598/v1

Obesity and microglial activation: potential for synergism in neurodegenerative diseases

Sheridan, P. A. (2010) · The FASEB Journal · doi:10.1096/fasebj.24.1_supplement.326.4 · Cited by 1 · see citing works

Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes

Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S., & Oka, J.-I. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.008 · Cited by 207 · see citing works